• The University of Western Australia (M504), 35 Stirling Highway,

    6009 Perth

    Australia

  • 1596 Citations
  • 20 h-Index
20072020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Dr Cheah is a Consultant Haematologist at Sir Charles Gairdner Hospital, Pathwest Laboratory Medicine WA and Hollywood Private Hospital. He received his MBBS from the University of Western Australia in 2003 and completed post-graduate training in Clinical and Laboratory Haematology in Perth (Fremantle Hospital) and Melbourne. He completed a Translational Research Fellowship at Peter MacCallum Cancer Centre (Melbourne, Australia) and an Advanced Lymphoma Fellowship at MD Anderson Cancer Center (Houston, Texas, USA).

Dr Cheah is the clinical lead for lymphoma at Sir Charles Gairdner Hospital, Director of the WA Lymphoma Centre of Research Excellence and Director of the Lymphoma Fellowship Program. His research interests are novel drug therapies and prevention of CNS relapse in lymphomas. He has authored >60 peer-reviewed publications, 6 book chapters, attracted >2.5 million dollars in competitive grant funding and reviews for major journals in the field. He was awarded Cancer Council WA Early Career Cancer Researcher of the Year in 2018 and is an internationally recognised lymphoma researcher. 

He is passionate about improving access for Australian patients to the novel lymphoma treatments and training the next generation of lymphoma researchers. He delights in his young family and enjoys running and cycling in his spare time.

Roles and responsibilities

Dr Cheah is a Clinical Haematologist with subspecialty expertise is in the management of lymphoma. He teaches Haematology at an undergraduate and post-graduate level through UWA and Sir Charles Gairdner Hospital.

He provides inpatient and outpatient care to patients through the Haematology Department at Sir Charles Gairdner Hospital and Hollywood Private Hospitals; as a pathologist he provides laboratory diagnostic services through Pathwest Laboratory Medicine WA. 

Future research

Developing an early phase clinical trials program exploring novel agents in patients with lymphoma.

Funding overview

AI, NHMRC project grant, 2013. "Phase I study of oral NMP in relapsed/refractory multiple myeloma." PI: Professor David Ritchie, Royal Melbourne Hospital.

 

NHMRC project grant 2018 APP 1142980

Title: Integrating immunity and genetics in Follicular Lymphoma to establish a prognostic score fit for the modern era

CIA: Maher Gandhi, CIG Chan Cheah

Value: $1,377,173

Medical Research Future Fund 2017 LCTRC APP 1152436

Title:An Open label, Multicentre, Phase I study of Ibrutinib, Rituximab and EBV specific T-cells in Patients with EBV-positive Primary or Secondary CNS Lymphoma unsuitable for standard therapies

CIA: Maher Gandhi, CIB Chan Cheah

Value: $1,586,476

 

Cancer Council WA collaborative cancer grant scheme 2017

Title: Designing better cellular and targeted therapies for lymphoma and leukaemia.

CIA: Bree Foley, CIC:Chan Cheah

Value: $50,000

Previous positions

Translational Research Fellow, Peter MacCallum Cancer Centre (Melbourne, Australia)
Lymphoma Fellow, MD Anderson Cancer Center (Houston, Texas, USA).

Industrial relevance

Principal investigator on numerous industry sponsored and academic cooperative group clinical trials.

Teaching overview

Lectures in Haematology in various units at UWA. Medical student supervisor through inpatient and outpatient clinics at Sir Charles Gairdner Hospital. 

Director of Fellowship Program at Sir Charles Gairdner Hospital / Blood Cancer Research WA.

Research

Dr Cheah performs clinical research focused on improving outcomes for patients with lymphoma.

Education/Academic qualification

Medicine, Doctor of Medical Science, University of Melbourne

Award Date: 14 Apr 2014

Medicine, MBBS, The University of Western Australia

Award Date: 23 Apr 2003

Research expertise keywords

  • lymphoma

Industry keywords

  • Drug Discovery
  • Medicine and Pharma
  • Biotechnology

Fingerprint Dive into the research topics where Chan Cheah is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A consensus statement on the use of biosimilar medicines in hematology in Australia

Gregory, G. P., Carrington, C., Cheah, C. Y., Hawkes, E. A., Irving, I. M., Siderov, J. & Opat, S., 1 Aug 2020, In : Asia-Pacific Journal of Clinical Oncology. 16, 4, p. 211-221 11 p.

Research output: Contribution to journalReview article

Open Access
  • 1 Citation (Scopus)

    Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic

    Di Ciaccio, P., McCaughan, G., Trotman, J., Ho, P. J., Cheah, C. Y., Gangatharan, S., Wight, J., Ku, M., Quach, H., Gasiorowski, R., Polizzotto, M. N., Prince, H. M., Mulligan, S., Tam, C. S., Gregory, G., Hapgood, G., Spencer, A., Dickinson, M., Latimer, M., Johnston, A. & 13 others, Armytage, T., Lee, C., Cochrane, T., Berkhahn, L., Weinkove, R., Doocey, R., Harrison, S. J., Webber, N., Lee, H. P., Chapman, S., Campbell, B. A., Gibbs, S. D. J. & Hamad, N., 1 Jun 2020, In : Internal Medicine Journal. 50, 6, p. 667-679 13 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Citation (Scopus)

    Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients

    Jakobsen, L. H., Ellin, F., Smeland, K. B., Wästerlid, T., Christensen, J. H., Jørgensen, J. M., Josefsson, P. L., Øvlisen, A. K., Holte, H., Blaker, Y. N., Grauslund, J. H., Bjørn, J., Molin, D., Lagerlöf, I., Smedby, K. E., Colvin, K., Thanarajasingam, G., Maurer, M. J., Habermann, T. M., Song, K. W. & 4 others, Zhu, K. Y., Gerrie, A. S., Cheah, C. Y. & El-Galaly, T. C., 1 May 2020, In : British Journal of Haematology. 189, 4, p. 661-671 11 p.

    Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Potentials, challenges and future of chimeric antigen receptor T-cell therapy in non-Hodgkin lymphomas

    El-Galaly, T. C., Cheah, C. Y., Kristensen, D., Hutchison, A., Hay, K., Callréus, T. & Villa, D., 2 Jul 2020, In : Acta Oncologica. 59, 7, p. 766-774 9 p.

    Research output: Contribution to journalReview article

  • Projects